Literature DB >> 17099096

Anthrax: a disease in waiting?

L Doganay1, L Dognany, P D Welsby.   

Abstract

Anthrax was a relatively unknown disease in the Western world until 2001, when spores were maliciously mailed in the US, causing five deaths. The mortality of the disease, the stability of its spores and the subsequent lack of person-to-person spread make anthrax an attractive biological weapon for terrorists with a desire for targeted mass destruction.

Entities:  

Mesh：

Year:  2006        PMID： 17099096      PMCID： PMC2660504          DOI： 10.1136/pgmj.2005.044487

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  11 in total

Review 1.  Anthrax.

Authors:  T C Dixon; M Meselson; J Guillemin; P C Hanna
Journal:  N Engl J Med       Date:  1999-09-09       Impact factor: 91.245

Review 2.  Recognition and management of anthrax--an update.

Authors:  M N Swartz
Journal:  N Engl J Med       Date:  2001-11-06       Impact factor: 91.245

3.  Emergency response to an anthrax attack.

Authors:  Lawrence M Wein; David L Craft; Edward H Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-21       Impact factor: 11.205

4.  The history of biologic warfare and bioterrorism.

Authors:  Michael K Jacobs
Journal:  Dermatol Clin       Date:  2004-07       Impact factor: 3.478

Review 5.  Anthrax as a biological weapon, 2002: updated recommendations for management.

Authors:  Thomas V Inglesby; Tara O'Toole; Donald A Henderson; John G Bartlett; Michael S Ascher; Edward Eitzen; Arthur M Friedlander; Julie Gerberding; Jerome Hauer; James Hughes; Joseph McDade; Michael T Osterholm; Gerald Parker; Trish M Perl; Philip K Russell; Kevin Tonat
Journal:  JAMA       Date:  2002-05-01       Impact factor: 56.272

6.  Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2001-10-26       Impact factor: 17.586

7.  Clinical issues in the prophylaxis, diagnosis, and treatment of anthrax.

Authors:  David M Bell; Phyllis E Kozarsky; David S Stephens
Journal:  Emerg Infect Dis       Date:  2002-02       Impact factor: 6.883

Review 8.  Anthrax.

Authors:  Kimberly A Wenner; Julie R Kenner
Journal:  Dermatol Clin       Date:  2004-07       Impact factor: 3.478

9.  Antimicrobial postexposure prophylaxis for anthrax: adverse events and adherence.

Authors:  Colin W Shepard; Montse Soriano-Gabarro; Elizabeth R Zell; James Hayslett; Susan Lukacs; Susan Goldstein; Stephanie Factor; Joshua Jones; Renee Ridzon; Ian Williams; Nancy Rosenstein
Journal:  Emerg Infect Dis       Date:  2002-10       Impact factor: 6.883

10.  Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings.

Authors:  Daniel B Jernigan; Pratima L Raghunathan; Beth P Bell; Ross Brechner; Eddy A Bresnitz; Jay C Butler; Marty Cetron; Mitch Cohen; Timothy Doyle; Marc Fischer; Carolyn Greene; Kevin S Griffith; Jeannette Guarner; James L Hadler; James A Hayslett; Richard Meyer; Lyle R Petersen; Michael Phillips; Robert Pinner; Tanja Popovic; Conrad P Quinn; Jennita Reefhuis; Dori Reissman; Nancy Rosenstein; Anne Schuchat; Wun-Ju Shieh; Larry Siegal; David L Swerdlow; Fred C Tenover; Marc Traeger; John W Ward; Isaac Weisfuse; Steven Wiersma; Kevin Yeskey; Sherif Zaki; David A Ashford; Bradley A Perkins; Steve Ostroff; James Hughes; David Fleming; Jeffrey P Koplan; Julie L Gerberding
Journal:  Emerg Infect Dis       Date:  2002-10       Impact factor: 6.883
View more
  5 in total

1.  Multiple ABC transporters are involved in the acquisition of petrobactin in Bacillus anthracis.

Authors:  Shandee D Dixon; Brian K Janes; Alexandra Bourgis; Paul E Carlson; Philip C Hanna
Journal:  Mol Microbiol       Date:  2012-03-20       Impact factor: 3.501

2.  Genetic analysis of petrobactin transport in Bacillus anthracis.

Authors:  Paul E Carlson; Shandee D Dixon; Brian K Janes; Katherine A Carr; Tyler D Nusca; Erica C Anderson; Sarra E Keene; David H Sherman; Philip C Hanna
Journal:  Mol Microbiol       Date:  2010-01-13       Impact factor: 3.501

3.  A case of septicaemic anthrax in an intravenous drug user.

Authors:  Arfon G M T Powell; Joseph E M Crozier; Heather Hodgson; David J Galloway
Journal:  BMC Infect Dis       Date:  2011-01-20       Impact factor: 3.090

4.  Confirmed Bacillus anthracis infection among persons who inject drugs, Scotland, 2009-2010.

Authors:  Malcolm Booth; Lindsay Donaldson; Xizhong Cui; Junfeng Sun; Stephen Cole; Susan Dailsey; Andrew Hart; Neil Johns; Paul McConnell; Tina McLennan; Benjamin Parcell; Henry Robb; Benjamin Shippey; Malcolm Sim; Charles Wallis; Peter Q Eichacker
Journal:  Emerg Infect Dis       Date:  2014-09       Impact factor: 6.883

Review 5.  Aerosol-Transmitted Infections-a New Consideration for Public Health and Infection Control Teams.

Authors:  Julian W Tang; Peter Wilson; Nandini Shetty; Catherine J Noakes
Journal:  Curr Treat Options Infect Dis       Date:  2015-07-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.